Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
FGFR3 inhib
Welcome,
Profile
Billing
Logout
45 Companies
42 Products
42 Products
384 Diseases
1197 Trials
26523 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
66
132
198
264
330
396
462
528
594
660
Focus V
(anlotinib) / Advenchen, Sino Biopharm
Lenvima
(lenvatinib) / Eisai, Merck (MSD)
Votrient
(pazopanib) / Novartis, BeiGene
nintedanib
/ Generic mfg.
dovitinib
(TKI258) / Novartis, Oncoheroes
Kinaction
(masitinib) / AB Science
Pemazyre
(pemigatinib) / Incyte
Balversa
(erdafitinib) / J&J
Retevmo
(selpercatinib) / Eli Lilly
Truseltiq
(infigratinib) / BridgeBio, Pfizer, Xediton Pharma
lucitanib
(E 3810) / Clovis, Servier
fexagratinib
(ABSK091) / Abbisko
Lytgobi
(futibatinib) / Otsuka
Voxzogo
(vosoritide) / BioMarin
rogaratinib
(BAY 1163877) / Bayer
derazantinib
(ARQ 087) / Merck (MSD)
tinengotinib
(TT-00420) / TransThera Biosci
ENMD-2076
/ CASI
tasurgratinib
(E7090) / Eisai
HMPL-453
/ Hutchmed
recifercept
(TA-46) / Pfizer
gunagratinib
(ICP-192) / InnoCare
RG7444
/ Roche
vofatamab
(B-701) / Rainier Therap
TYRA-300
/ Tyra Biosci
zoligratinib
(Debio 1347) / Debiopharm
HH185
/ CSPC Pharma, HaiHe Biopharma
LY2874455
/ Eli Lilly
SAR442501
/ Sanofi
SKI-G-801
/ Oscotec
ABSK061
/ Abbisko
ABSK121
/ Abbisko
ASP5878
/ Astellas
CPL304110
/ Celon Labs
FPI-1966
/ Fusion Pharma
KIN-3248
/ Kinnate Biopharma
LOXO-435
/ Eli Lilly
PRN1371
/ Sanofi
R3Mab
/ Roche
S-49076
/ Servier
TT-00434
/ TransThera Biosci
TYRA-200
/ Tyra Biosci
